Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002-Reference-Cited by-同舟云学术

Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002

Published:2007-08 Issue:4 Volume:16 Page:344-351
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Ernst Miranda F.,van de Poll-Franse Lonneke V.,Roukema Jan A.,Coebergh Jan Willem W.,van Gestel Cornelia M.J.,Vreugdenhil Gerard,Louwman Marieke J.,Voogd Adri C.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference18 articles.

1. Differences in stage and therapy for breast cancer across Europe;Sant;Int J Cancer,2001

2. Breast carcinoma survival in Europe and the United States;Sant;Cancer,2004

3. Survival after treatment for breast cancer in a geographically defined population;Tejler;Br J Surg,2004

4. Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening;Ernst;Cancer,2004

5. Cancer incidence, care and survival in the South of the Netherlands, 1955–1999: a report of the Eindhoven cancer registry with cross-border implications;Coebergh,2001

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic breast cancer in Kenya: survival, prognosis and management at a tertiary referral centre;ecancermedicalscience;2023-06-27

2. Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group;Cancers;2023-03-08

3. Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference—a Dutch population-based study from 2008 to 2018;Breast Cancer Research and Treatment;2023-01-17

4. Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference - a Dutch population based study from 2008-2018.;2022-08-08

5. Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer;JCO Clinical Cancer Informatics;2021-08